Lee's plans China depression drug sales
This article was originally published in Scrip
Executive Summary
Hong Kong-based Lee's Pharmaceutical's China registration study of anti-depressant Trittico (trazodone) met its primary endpoint – enabling the firm to submit an import drug license application by the end of the year.